AC
Amia Capital Portfolio holdings
AUM
$32.1M
This Quarter Return
-23.52%
1 Year Return
-3.89%
3 Year Return
+25.64%
5 Year Return
–
10 Year Return
–
AUM
$112M
AUM Growth
+$112M
(-67%)
Cap. Flow
-$150M
Cap. Flow
% of AUM
-134.13%
Top 10 Holdings %
Top 10 Hldgs %
85.77%
Holding
48
New
6
Increased
2
Reduced
31
Closed
8
Top Buys
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$463K |
| 2 |
Arvinas
ARVN
|
$436K |
| 3 |
Scholar Rock
SRRK
|
$278K |
| 4 |
MTEM
Molecular Templates, Inc.
MTEM
|
$250K |
| 5 |
Kezar Life Sciences
KZR
|
$59K |
Top Sells
Sector Composition
| 1 | Healthcare | 54.12% |
| 2 | Communication Services | 4.35% |
| 3 | Materials | 3.33% |
| 4 | Energy | 0.05% |
| 5 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Grifois
GRFS
$6.78B
| $36.3M | 32.3% | 1,803,856 -354,050 | -16% | -$7.13M |
|
|
LSXMA
2
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $21.3M | 18.93% | 671,741 -871,175 | -56% | -$27.6M |
|
|
LSXMK
3
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $12.6M | 11.19% | 398,035 -564,061 | -59% | -$17.8M |
|
|
BBL
4
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
| $6.95M | 6.18% | 228,919 -163,209 | -42% | -$4.95M |
|
5
Liberty Latin America Class A
LILA
$1.61B
| $4.89M | 4.34% | 464,399 -140,170 | -23% | -$1.47M |
|
6
Vale
VALE
$43.9B
| $3.73M | 3.32% | 450,000 -350,000 | -44% | -$2.9M |
|
7
Ionis Pharmaceuticals
IONS
$6.79B
| $3.29M | 2.93% | 69,678 -22,834 | -25% | -$1.08M |
|
8
Vertex Pharmaceuticals
VRTX
$100B
| $2.57M | 2.29% | 10,809 -3,588 | -25% | -$854K |
|
9
Neurocrine Biosciences
NBIX
$13.8B
| $2.44M | 2.17% | 28,139 -6,633 | -19% | -$574K |
|
10
Incyte
INCY
$16.5B
| $2.17M | 1.93% | 29,635 -10,382 | -26% | -$760K |
|
11
Alnylam Pharmaceuticals
ALNY
$58.5B
| $1.52M | 1.35% | 13,946 -3,957 | -22% | -$431K |
|
12
Moderna
MRNA
$9.37B
| $1.26M | 1.12% | 41,993 -11,083 | -21% | -$332K |
|
13
Halozyme
HALO
$8.56B
| $1.25M | 1.11% | 69,409 -20,164 | -23% | -$363K |
|
14
iShares Biotechnology ETF
IBB
$5.6B
| $1.21M | 1.07% | 11,207 -33,232 | -75% | -$3.58M |
|
15
Agios Pharmaceuticals
AGIO
$2.19B
| $1.21M | 1.07% | 33,958 -5,312 | -14% | -$188K |
|
16
argenx
ARGX
$43.6B
| $1.09M | 0.96% | 8,235 -1,785 | -18% | -$235K |
|
|
ALXN
17
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $1.03M | 0.91% | 11,452 -3,394 | -23% | -$305K |
|
18
Esperion Therapeutics
ESPR
$448M
| $1.02M | 0.91% | 32,492 -8,071 | -20% | -$254K |
|
|
RDUS
19
DELISTED
Radius Health, Inc.
RDUS
| $780K | 0.69% | 59,983 -15,616 | -21% | -$203K |
|
|
MYOK
20
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $517K | 0.46% | 11,019 -2,597 | -19% | -$122K |
|
|
ITCI
21
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $463K | 0.41% | +30,144 | New | +$463K |
|
|
22
Arvinas
ARVN
$568M
| $436K | 0.39% | +10,815 | New | +$436K |
|
23
Exelixis
EXEL
$10.1B
| $426K | 0.38% | 24,712 -5,384 | -18% | -$92.8K |
|
24
Nektar Therapeutics
NKTR
$568M
| $408K | 0.36% | 22,842 -4,186 | -15% | -$74.8K |
|
|
ICPT
25
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $382K | 0.34% | 6,067 -1,611 | -21% | -$101K |
|